1. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. Issue 12 (December 2022) Authors: Eikelboom, John W; Jolly, Sanjit S; Belley-Cote, Emilie P; Whitlock, Richard P; Rangarajan, Sumathy; Xu, Lizhen; Heenan, Laura; Bangdiwala, Shrikant I; Tarhuni, Wadea M; Hassany, Mohamed; Kontsevaya, Anna; Harper, William; Sharma, Sanjib Kumar; Lopez-Jaramillo, Patricio; Dans, Antonio L; Palileo-... Journal: Lancet Issue: Volume 10:Issue 12(2022) Page Start: 1160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. Issue 12 (December 2022) Authors: Eikelboom, John W; Jolly, Sanjit S; Belley-Cote, Emilie P; Whitlock, Richard P; Rangarajan, Sumathy; Xu, Lizhen; Heenan, Laura; Bangdiwala, Shrikant I; Luz Diaz, Maria; Diaz, Rafael; Yusufali, Afzalhussein; Kumar Sharma, Sanjib; Tarhuni, Wadea M; Hassany, Mohamed; Avezum, Alvaro; Harper, William;... Journal: Lancet Issue: Volume 10:Issue 12(2022) Page Start: 1169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗